Magnetar Financial’s Ibere Pharmaceuticals IBER Stock Holding History

Magnetar Financial’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-785,872	Closed	-$7.93M	–	893
2022 Q4	$7.93M	Hold	785,872	–	–	0.13%	173
2022 Q3	$7.79M	Buy	785,872 +714,490	+1,001%	+$7.05M	0.11%	219
2022 Q2	$700	Buy	+71,382	New	+$700K	0.01%	1064

Magnetar Financial's IBER Position: Q1 2023 in Review

Magnetar Financial sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 785,872 shares — an estimated $7.93M sold.

Magnetar Financial first reported a position in IBER in Q2 2022 and held it in 3 quarters. The position peaked at $7.93M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Magnetar Financial reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Magnetar Financial sold 785,872 Ibere Pharmaceuticals shares in Q1 2023, an estimated $7.93M.
Magnetar Financial first reported a position in Ibere Pharmaceuticals in Q2 2022 and held it in 3 quarters.
Magnetar Financial's Ibere Pharmaceuticals position peaked at $7.93M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.